NASDAQ:AMED
Amedisys Inc Stock News
$92.46
+0.170 (+0.184%)
At Close: Mar 27, 2024
Amedisys Completes Acquisition of Home Health Assets from AssistedCare Home Health and AssistedCare of the Carolinas
12:00pm, Monday, 04'th Apr 2022 GlobeNewswire Inc.
BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its acquisit
Why Is Amedisys (AMED) Up 13.2% Since Last Earnings Report?
03:30pm, Friday, 25'th Mar 2022 Zacks Investment Research
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Amedisys (AMED) Up 13.2% Since Last Earnings Report?
01:32pm, Friday, 25'th Mar 2022
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?
Ukraine Has Received $100M In Crypto Donations: Here''s Where The Funds Are Going
10:11am, Monday, 14'th Mar 2022 Benzinga
Ukraine has received nearly $100 million worth of cryptocurrency donations, according to a report from CoinDesk . What Happened: Alex Bornyakov, Ukraine’s Deputy Minister for Digital Transformation, revealed that over $60 million of the funds had been sent to the main fund run by Ukrainian cryptocurrency exchange Kuna. The rest of the funds have been sent to several smaller funds, Bornyakov said in an emergency online briefing entitled "Digital Resistance: How Ukraine Is Leveraging Technology to Fight for Freedom.” Crypto assets proved extremely helpful in facilitation of funding flows to the Amed Forces of … Full story available on Benzinga.com
New Strong Sell Stocks for March 9th
12:45pm, Wednesday, 09'th Mar 2022 Zacks Investment Research
AGESY, AMED, and APAM have been added to the Zacks Rank #5 (Strong Sell) List on March 9, 2022.
New Strong Sell Stocks for March 9th
09:02am, Wednesday, 09'th Mar 2022
AGESY, AMED, and APAM have been added to the Zacks Rank #5 (Strong Sell) List on March 9, 2022.
Amedisys to Present at Multiple Healthcare Conferences in March
01:00pm, Tuesday, 08'th Mar 2022 GlobeNewswire Inc.
BATON ROUGE, La., March 08, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Chri
Amedisys to Present at Multiple Healthcare Conferences in March
08:00am, Tuesday, 08'th Mar 2022
BATON ROUGE, La., March 08, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Chris
New Strong Sell Stocks for March 4th
02:01pm, Friday, 04'th Mar 2022 Zacks Investment Research
AMED, CACC, and EXPO have been added to the Zacks Rank #5 (Strong Sell) List on March 4, 2022
New Strong Sell Stocks for March 4th
11:32am, Friday, 04'th Mar 2022
AMED, CACC, and EXPO have been added to the Zacks Rank #5 (Strong Sell) List on March 4, 2022
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
03:04pm, Tuesday, 01'st Mar 2022 Benzinga
Upgrades
Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71, compared to year-ago quarter
Benzinga''s Top Ratings Upgrades, Downgrades For March 1, 2022
03:04pm, Tuesday, 01'st Mar 2022 Benzinga
Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ: RVMD ) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of $50.88 and a 52-week-low of $18.07. At the end of the last trading period, Revolution Medicines closed at $18.92. According to UBS, the prior rating for Amedisys Inc (NASDAQ: AMED ) was changed from Sell to Neutral. For the fourth quarter, Amedisys had an EPS of $1.18, compared to year-ago quarter EPS of $1.49. At the moment, the stock has a 52-week-high of $292.97 and a 52-week-low of $122.12. Amedisys closed at $160.24 at the end of the last trading period. For Sunstone Hotel Investors Inc (NYSE: SHO ), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. At the moment, the stock has a 52-week-high of $13.91 and a 52-week-low of $9.93. Sunstone Hotel Invts closed at $10.58 at the end of the last trading period. Wedbush upgraded the previous rating for Logitech International SA (NASDAQ: LOGI ) from Neutral to Outperform.
Amedisys to Present at the Raymond James & Associates’ 43rd Annual Institutional Investors Conference
01:00pm, Monday, 28'th Feb 2022 GlobeNewswire Inc.
BATON ROUGE, La., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Chris
Amedisys to Present at the Raymond James & Associates’ 43rd Annual Institutional Investors Conference
01:00pm, Monday, 28'th Feb 2022 GlobeNewswire
BATON ROUGE, La., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Chris Gerard, President and Chief Operating Officer and Scott Ginn, Executive Vice President and Chief Financial Officer, will present at the Raymond James & Associates’ 43 rd Annual Institutional Investors Conference on Tuesday, March 8, at 11:35 a.m. EST.
Amedisys to Present at the Raymond James & Associates' 43rd Annual Institutional Investors Conference
08:00am, Monday, 28'th Feb 2022
BATON ROUGE, La., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Chris G